OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
51 hedge funds and large institutions have $17.6M invested in Orexigen Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 6 closing their positions.
Holders
51
Holders Change
-1
Holders Change %
-1.92%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
8
Reduced
18
Closed
6
Calls
$1.02M
Puts
$836K
Net Calls
+$186K
Net Calls Change
-$241K
Top Buyers
| 1 |
HCM
1
Highbridge Capital Management
New York
|
$132K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$61K |
| 3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$57K |
| 4 |
4
Citigroup
New York
|
$37K |
| 5 |
5
BlackRock
New York
|
$653K |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$756K |
| 2 |
GL
2
GLG LLC
New York
|
$0 |
| 3 |
EC
3
EcoR1 Capital
San Francisco,
California
|
$0 |
| 4 |
JG
4
Jefferies Group
New York
|
$0 |
| 5 |
VKH
5
Virtu KCG Holdings
New York
|
$41K |
